Source: GlobeNewswire

Press Release: Arctic Vision : Clearside Biomedical Expands XIPERE License Agreement with Arctic Vision to Include Australia, New Zealand, India and ASEAN Countries

- Increasing Global Awareness of Innovative Suprachoroidal Injection Platform - - Increasing Global Awareness of Innovative Suprachoroidal Injection Platform -

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Eddy Wu's photo - Founder & CEO of Arctic Vision

Founder & CEO

Eddy Wu

CEO Approval Rating

90/100

Read more